ftzy.com.cn (PTHL) - Long-Term Debt to Capital Coefficient

Pheton Holdings - graphic logo of issuer PTHL

Pheton Holdings Ltd (PTHL) dominates the brachytherapy laser systems niche, leveraging strict regulatory barriers in China. The ratio of long-term loans to equity demonstrates financial stability, where the 0.00 mark characterizes this parameter. The company's software precision minimizes tissue damage, while the deep integration of proprietary software into clinics ensures a steady stream of subscription revenue.

ftzy.com.cn (PTHL): Long-Term Debt to Equity from 09/06/2024 to 01/16/2026

Comprehensive metric breakdowns and analytics for Pheton Holdings Limited (PTHL)

- stock price and consensus target price:
Quote Chart Pheton|PTHL - Analyst Consensus Forecast
- market capitalization indicators:
Market Value Pheton Holdings Ltd|PTHL - Enterprise Value
- balance sheet net asset value indicators:
Book Value per Share Pheton Holdings|PTHL - Company Book Value|Market Value to Book Value ftzy.com.cn|PTHL - Aggregate Company Assets
- debt and solvency information:
Total Debt to Equity Ratio Pheton Holdings Ltd|PTHL - Long-Term Debt to Capital|Short-Term Debt to Capital Pheton|PTHL - Company Total Debt|Debt to Net Assets Ratio Pheton Holdings Ltd|PTHL - Company Long-Term Debt|Short-Term Debt Pheton Holdings|Intermediate Liquidity Ratio ftzy.com.cn
- net income and valuation ratios data:
PTHL - Net Profit
General company analysis:ftzy.com.cn - PTHL
Signature product of Pheton Holdings Limited

Investors seek asset stability by analyzing the financing structure. Stable B2B revenues from medical software at Pheton Holdings Ltd. (PTHL) enable the efficient servicing of borrowed funds. The long-term debt-to-equity ratio reflects the weight of obligations with maturities exceeding one year relative to equity. This ratio reveals the extent to which business development depends on external lending. Low values confirm the financial autonomy and reliability of the company.

Analysis of competing companies

Haleon PLC - Long-Term Liabilities to Equity|Long-Term Debt to Capital KVUE|VRNA (Verona Pharma Inc.) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital MENS (Jyong Biotech Ltd)|Long-Term Debt to Capital ligand.com LGND|AMRX - Long-Term Debt to Equity|Long-Term Debt to Capital Coefficient PRGO (Perrigo Company PLC)|Alvotech Corp (ALVO) - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio Liquidia Inc.|GLPG (Galapagos NV) - Long-Term Debt to Capital|Long-Term Debt to Capital anipharmaceuticals.com|Long-Term Debt to Equity Ratio MNKD (MannKind)|AMPH (Amphastar Pharmaceuticals Inc) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Equity Pacira PCRX|ARS Corp (SPRY) - Long-Term Liabilities to Capital|TBPH: Long-Term Debt to Equity Ratio|aquestive.com - Long-Term Loans to Capital Ratio|SCPH: Long-Term Debt to Capital|Tectonic Therapeutic - Long-Term Debt to Capital Coefficient|TNXP (Tonix Pharmaceuticals Inc.) - Long-Term Debt to Capital|Long-Term Liabilities to Capital SXT China SXTC|Long-Term Debt to Equity Eupraxia Pharmaceuticals (EPRX)|BHST (bioharvest.com) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Equity eXoZymes EXOZ|ORMP (Oramed) - Long-Term Liabilities to Equity|Entera Bio Corp - Long-Term Debt to Capital|Long-Term Debt to Capital Coefficient HYFT (MindWalk Therapeutics)|ABVC: Long-Term Debt to Capital|Long-Term Liabilities to Capital cumberlandpharma.com (CPIX)|Long-Term Debt to Equity Ratio QNTM|FGEN (FibroGen Inc) - Long-Term Loans to Capital Ratio|Long-Term Debt to Equity Telomir Pharma (TELO)|RANI - Long-Term Liabilities to Capital|Long-Term Debt to Equity Synergy CHC SNYR|RLYB: Long-Term Debt to Capital Ratio|LEXX: Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Coefficient PULM (Pulmatrix Inc)|APM: Long-Term Debt to Capital|Lyra Therapeutics Inc - Long-Term Debt to Capital Coefficient|Long-Term Debt to Equity Impact BioMedical Inc|Long-Term Liabilities to Capital TNF Pharma TNFA|Long-Term Debt to Equity cbdMD, Inc. (YCBD)|Long-Term Debt to Equity PRFX (PainReform Ltd)|Long-Term Debt to Capital CYTO (Altamira Therapeutics Ltd.)|LIPO: Long-Term Debt to Capital Ratio|OptiNose, Inc. - Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital pieris.com PIRS|Procaps (PROC) - Long-Term Debt to Equity|Long-Term Debt to Capital Ratio PTPI|QLI (Qilian International Holding Group Limited) - Long-Term Debt to Capital|SLRN - Long-Term Indebtedness to Equity|Long-Term Debt to Equity TFF Pharmaceuticals (TFFP)